Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly EBT Margin of 493.91% for Q1 2026, down 48168.0% year-over-year from N/an in Q1 2025, and down 14721.61% quarter-over-quarter from 3.33% in Q4 2025.
Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' EBT Margin history runs 6 years deep, the most recent figure standing at 493.91% for Q1 2026.
- In Q1 2026, EBT Margin fell 48168.0% year-over-year to 493.91%; the TTM figure through Mar 2026 stood at 140.0% (down 11999.0% YoY), while the FY2025 annual figure was 4.11%, up 2169.0% from the prior year.
- EBT Margin for Q1 2026 stood at 493.91%, down from 3.33% in the prior quarter.
- The five-year high for EBT Margin was 1.99% in Q3 2025, with the low at 493.91% in Q1 2026.
- The 5-year median for EBT Margin is 48.9% (2023), against an average of 106.16%.
- Peak annual rise in EBT Margin reached 75192 bps in 2022, while the deepest fall reached 195580 bps in 2022.
- Mirum Pharmaceuticals' EBT Margin stood at 130.05% in 2022, then surged by 61 bps to 50.94% in 2023, then soared by 52 bps to 24.51% in 2024, then surged by 86 bps to 3.33% in 2025, then tumbled by 14722 bps to 493.91% in 2026.
- Business Quant data shows MIRM's EBT Margin at 493.91% in Q1 2026, 3.33% in Q4 2025, and 1.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | -37.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.19% |
| Mar 31, 2026 | -493.91% |
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | 1.99% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | -24.51% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -30.82% |
| Mar 31, 2024 | -35.62% |
| Dec 31, 2023 | -50.94% |
| Sep 30, 2023 | -48.90% |
| Jun 30, 2023 | -196.61% |
| Mar 31, 2023 | -94.72% |
| Dec 31, 2022 | -130.05% |
| Sep 30, 2022 | -190.06% |
| Jun 30, 2022 | -191.56% |
| Mar 31, 2022 | -283.86% |
| Dec 31, 2021 | 1,825.75% |
| Sep 30, 2021 | -941.98% |